Beranda › Migrain › North Carolina
Uji klinis Migrain di North Carolina
12 studi untuk Migrain mencari peserta di lokasi di North Carolina.
Kota di North Carolina
Teks studi resmi (Bahasa Inggris)
Study of EVO756 in Adults With Migraine
- Asheville Neurology Specialists, Pa, Asheville
- Eximia Research NC, Raleigh
Menerima pesertaFase 2
Usia 18 hingga 64 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07616128A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine
- Accellacare - Piedmont, Statesville
- Accellacare of Piedmont HealthCare, Statesville
- Accellacare US Inc., Winston-Salem
Menerima pesertaFase 1
Usia 6 hingga 11 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT06995729Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- OnSite Clinical Solutions, LLC, Charlotte
Menerima pesertaFase 3
Usia 6 hingga 17 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT04743141Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- OnSite Clinical Solutions, LLC, Charlotte
Menerima pesertaFase 3
Usia 6 hingga 17 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT04649242Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- Onsite Clinical Solutions Park Cedar Dr., Charlotte
- Onsite Clinical Solutions Mecklenburg, Charlotte
- Onsite Clinical Solutions Ballantyne, Charlotte
- dan 2 lainnya
Menerima pesertaFase 4
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT06972056Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Onsite Clinical Solutions - Don Lochman Lane - Charlotte /ID# 282834, Charlotte
Menerima pesertaFase 3
Usia 6 hingga 17 · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT05125302A Pivotal Clinical Study to Evaluate the MySalvia System for the Treatment of Resistant Migraine
- Queen City Clinical Research, PLLC, Charlotte
Menerima peserta
Usia 22 hingga 84 · Semua jenis kelamin · Diperbarui 28 Agu 2026 · NCT07719608A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- OnSite Clinical Solutions, Charlotte
- Guildford Neurologic Research Partners, LLC, Greensboro
- Headache Wellness Center, Greensboro
- dan 2 lainnya
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 20 Agu 2026 · NCT07645924BE WELL With Migraine: Brain Education and WELLness With Migraine
- Wake Forest University Health Sciences, Winston-Salem
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 12 Jun 2026 · NCT05987592Observational Study to Assess Maternal, Fetal and Infant Outcomes Following Exposure to Rimegepant
- Evidera, a PPD business unit, Wilmington
Menerima pesertaStudi observasional
Usia 0 ke atas · Wanita · Diperbarui 5 Mei 2026 · NCT05046613Observational Study to Assess Adverse Events When Adult Female Participants Are Treated With Ubrelvy (Ubrogepant) or Qulipta (Atogepant) During Pregnancy
- Iqvia /Id# 266904, Durham
Menerima pesertaStudi observasional
Usia 18 ke atas · Wanita · Diperbarui 15 Des 2025 · NCT05158894Aimovig Pregnancy Exposure Registry
- IQVIA Virtual Site, Durham
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 hingga 99 · Wanita · Diperbarui 4 Nov 2025 · NCT06150781Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.